The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials

Bibliographic Details
Main Authors:	Xiaofen Jin, Lianfang Wu, Ji Wang, Malong Feng
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-01-01
Series:	Advances in Dermatology and Allergology
Subjects:	fluticasone propionate/formoterol propionate/salmeterol paediatric asthma randomized controlled trials meta-analysis
Online Access:	https://www.termedia.pl/The-comparison-of-fluticasone-propionate-formoterol-with-fluticasone-propionate-salmeterol-for-paediatric-asthma-a-meta-analysis-of-randomized-controlled-trials,7,39685,1,1.html

Similar Items

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
by: Cheng SL, et al.
Published: (2021-02-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
by: Cheng SL, et al.
Published: (2020-12-01)

Effect of combined application of tiotropium and Salmeterol and fluticasone propionate powder on disease control in stable COPD patients
by: Xiu-Ping Han, et al.
Published: (2016-06-01)

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study
by: Jean Bousquet, et al.
Published: (2017-04-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
by: Moretz C, et al.
Published: (2020-10-01)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

In vitro aerodynamic analysis of co-spray dried fluticasone propionate (FP) and salmeterol xinafoate (SX) dry powder inhalation aerosols with lactose-alternative excipient
by: Malapit, Monica, et al.
Published: (2017)

Optimal step-down approach for pediatric asthma controlled by salmeterol/fluticasone: A randomized, controlled trial (OSCAR study)
by: Kenichi Akashi, et al.
Published: (2016-07-01)

Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01)

The Clinical Evaluation of the Acceptance of Fluticasone Propionate Diskus® by Older Japanese Patients with Bronchial Asthma
by: Hiroyuki Ohbayashi
Published: (2005-01-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
by: Belchamber KBR, et al.
Published: (2018-09-01)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01)

The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01)

Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
by: Abhinav Kumar, et al.
Published: (2020-01-01)

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone
by: Raisha G. Dalvi, et al.
Published: (2019-04-01)

Effects of Salmeterol Xinafoate and Fluticasone Propionate on Immunological Activation of Human Cultured Mast Cells
by: Hirotomo Akabane, et al.
Published: (2006-01-01)

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
by: Hasegawa, Yoshinori, et al.
Published: (2012)

Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)

Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017-10-01)

Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis
by: Ashraf Velayati, et al.
Published: (2015-01-01)

Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+ </sup>regulatory T cells in COPD
by: Yang Li, et al.
Published: (2011-10-01)

Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity
by: Dai Jiajia, et al.
Published: (2015-01-01)

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
by: Marina G. Dogbe, et al.
Published: (2019-10-01)

Comparison of Rapid Bronchodilatory Effects of Salmeterol and Formoterol in Patients with Moderate to Severe Asthma
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
by: Philip Lance A. Liu, et al.
Published: (2010-06-01)

A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone
by: Masayuki Hojo, et al.
Published: (2014-01-01)

Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
by: Bhanu Prakash Kolasani, et al.
Published: (2013-09-01)

Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
by: Perrone V, et al.
Published: (2016-11-01)

A randomized trial of symptom-based management in Japanese patients with COPD
by: Betsuyaku T, et al.
Published: (2018-08-01)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010-02-01)

Quantitative proton nuclear magnetic resonance method for simultaneous analysis of fluticasone propionate and azelastine hydrochloride in nasal spray formulation
by: Amal A. El-Masry, et al.
Published: (2021-07-01)

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
by: Furuhashi K, et al.
Published: (2019-09-01)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial
by: Papi Alberto, et al.
Published: (2012-06-01)

Supercritical CO<sub>2</sub> Extraction of Organic Solvents from Flunisolide and Fluticasone Propionate
by: Lucia Baldino, et al.
Published: (2021-04-01)

Simultaneous High Performance Liquid Chromatography Assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco™ Lavare Wound Base
by: Troy Purvis
Published: (2015-11-01)

An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients
by: Rahul Sharma, et al.
Published: (2021-01-01)